anonymous
Guest
anonymous
Guest
Gator numbers are my latest spank bank material
These number get me hard
These number get me hard
Take a look at Steglatro. ADA meeting highlighted what this drug is doing for diabetes and explains why it is the fasting growing diabetes drug on market. Congratulations Merck and the entire sales team. You are making a difference in people’s livesGator numbers are my latest spank bank material
These number get me hard
Take a look at Steglatro. ADA meeting highlighted what this drug is doing for diabetes and explains why it is the fasting growing diabetes drug on market. Congratulations Merck and the entire sales team. You are making a difference in people’s lives
If Steglatro is doing so well, how come you never hear anything about it from Merck?The ADA was overwhelmed with Steglatro as well as all the competitive companies. Look at Gator and you will see why.. The numbers are unbelievable
Merck had their investor meeting today and highlighted how the industry is shitting their pants because of how great Steglatro is doing but the real message is the new info about Steglatro which will send Steglatro to the the number one drug in the worldIf Steglatro is doing so well, how come you never hear anything about it from Merck?
What is your Steglatro share 1%yea, in the field competitive reps are shitting themselves cuz my Steglatro foot is squarely up thier ass and they are scared.
Merk is poised to own the diabetes market. Hell, Novo and Lilly will need to downsize soon.
So many fat fucks keep eating cherry pie all day and wash that down with coke so they need mother merck and her great industry leading world class drugs. We are the best trained sales force in the industry, we by miles have the best coaches and our marketing team is unstoppable.
Merck will rule the world and maybe annoint Trump as King.
I think it is more like 8% but still behind the eight ballI believe nationally Steglatro share is under 5% of the SGLT2 market. This has not been a money maker
Check out Gator. Steglatro is leading the SGLT2 class in new prescription growth. This is a significant drug in physician’s fight against diabetessteglatro will be the highest selling drug of all time next year. it will go from 4 out of every 100 scripts in its own class to more scripts than all other diabetes meds combined. Buy MRK now
Have you seen the latest Steglatro numbers. It is easily beating Belsomra.Steglatro has to be Merck’s most successful launch. What a company. What a drug. The market share keeps doubling each week.
What is the market share in the SGLT2 class for Steglatro? I am looking to invest in Merck and know Merck has Januvia and a SGLT2. Figured the Steglatro was doing well considering how well Januvia doesHave you seen the latest Steglatro numbers. It is easily beating Belsomra.
Steglatro passed Jardiance as the number 1 SGLT2. Congratulations Merck!Steglatro is starting to make a major difference for Merck. Share nationally is 6 and growing
Steglatro is now the most successful launch since Januvia!Steglatro passed Jardiance as the number 1 SGLT2. Congratulations Merck!